| Cardiac | Stroke | Mortality | Composite |
---|
eGFR < 60 | 1.38 (1.15, 1.65) | 1.49 (1.18, 1.87) | 1.83 (1.61, 2.08) | 1.58 (1.41, 1.77) |
eGFR Decline | 1.20 (1.00, 1.45) | 1.51 (0.97, 2.35) | 1.42 (1.24, 1.64) | 1.32 (1.17, 1.49) |
eGFR Increase | 1.25 (0.88, 1.77) | 1.25 (0.97, 1.61) | 1.21 (0.91, 1.62) | 1.09 (0.85, 1.40) |
eGFR ≥60 | Reference | Reference | Reference | Reference |
- Models are adjusted for age, sex, race, study, education, diabetes, history of cardiovascular disease, history of hypertension, alcohol use, smoking status, systolic blood pressure, waist-to-hip ratio, left ventricular hypertrophy, non-HDL cholesterol, and albumin.
- Differences between eGFR increase and decline groups non-significant for cardiac (p = 0.86), stroke (p = 0.45), mortality (p = 0.31), and composite (0.16) outcomes.